ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

38.34 -2.49 (-6.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,367,619
Open	40.85
Bid (Size)	38.00 (1,000)
Ask (Size)	40.99 (100)
Prev. Close	40.83
Today's Range	38.00 - 40.85
52wk Range	32.99 - 117.33
Shares Outstanding	115,926,629
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Today 10:12 EST

From Bernstein Liebhard LLP

Via GlobeNewswire

CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations

Today 8:00 EST

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	+0.4%	+0.4%
1 Month	+2.6%	+2.6%
3 Month	-51.1%	-51.1%
6 Month	-47.3%	-47.3%
1 Year	-43.7%	-43.7%

More News

CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations

Today 8:00 EST

Via TheNewswire.com

CORCEPT THERAPEUTICS INVESTIGATION ALERT: Corcept Therapeutics Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

February 11, 2026

Via NewMediaWire

CORCEPT THERAPEUTICS INVESTIGATION ALERT: Corcept Therapeutics Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

February 11, 2026

Via TheNewswire.com

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

February 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

February 09, 2026

From Schall Law

Via GlobeNewswire

CORT SECURITIES INVESTIGATION: Kaplan Fox is Investigating Possible Securities Violations Against Corcept Therapeutics, Inc. (CORT)

February 07, 2026

Via NewMediaWire

CORT SECURITIES INVESTIGATION: Kaplan Fox is Investigating Possible Securities Violations Against Corcept Therapeutics, Inc. (CORT)

February 07, 2026

Via TheNewswire.com

CORCEPT THERAPEUTICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

February 06, 2026

Via NewMediaWire

CORCEPT THERAPEUTICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

February 06, 2026

Via TheNewswire.com

CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Possible Securities Law Violations

February 05, 2026

Via NewMediaWire

CORCEPT THERAPEUTICS SECURITIES INVESTIGATION: Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Possible Securities Law Violations

February 05, 2026

Via TheNewswire.com

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

February 05, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

CORCEPT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Corcept Therapeutics Investors to Contact the Firm Regarding Ongoing Investigation

February 04, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

February 04, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

February 04, 2026

Via NewMediaWire

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

February 04, 2026

Via TheNewswire.com

3 Profitable Stocks with Warning Signs

February 03, 2026

Via StockStory

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

February 03, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

February 03, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Corcept Therapeutics Incorporated – CORT

February 03, 2026

From Pomerantz LLP

Via GlobeNewswire

CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations

February 03, 2026

Via NewMediaWire

CORCEPT THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations

February 03, 2026

Via TheNewswire.com

CORT FRAUD INVESTIGATION: Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to Potential Securities Violations

February 02, 2026

Via NewMediaWire

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?

Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.

What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?

Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?

The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market

What is the current price of Corcept Therapeutics Incorporated - Common Stock?

The current price of Corcept Therapeutics Incorporated - Common Stock is 38.34

When was Corcept Therapeutics Incorporated - Common Stock last traded?

The last trade of Corcept Therapeutics Incorporated - Common Stock was at 02/12/26 04:00 PM ET

What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?

The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 4.44B

How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?

Corcept Therapeutics Incorporated - Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.